# Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)

> **NCT05139797** · — · RECRUITING · sponsor: **Cedars-Sinai Medical Center** · enrollment: 300 (estimated)

## Conditions studied

- Cardiac Amyloidosis

## Interventions

- **OTHER:** EchoNet-LVH screening for cardiac amyloidosis

## Key facts

- **NCT ID:** NCT05139797
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-18
- **Primary completion:** 2026-01-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05139797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05139797, "Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05139797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*